• 出版社/出版日：360iResearch / 2022年10月11日
|Single User（1名利用、印刷可）||￥643,370 (USD4,949)||▷ お問い合わせ|
|Enterprise License（企業利用、印刷可）||￥1,293,370 (USD9,949)||▷ お問い合わせ|
|360iResearch社の当調査資料によると、2021年に42.78百万ドルであった世界の静脈可視化装置市場規模は2022年に55.14百万ドルとなり、2027年までに年平均29.12％成長して198.33百万ドルまで拡大すると見込まれています。当書は、静脈可視化装置の世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別分析（近赤外照明、透過照明）、用途別分析（採血、静脈アクセス）、エンドユーザー別分析（学術機関、献血所、病院）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、Accuvein, Inc.、AIMVEIN LTD.、ANANDIC MEDICAL SYSTEMS INC、BLZ Technology Inc.,、CAREstream Group、Kizlon、Koninklijke Philips N.V.、MedicalDeals、Medline Industries, Inc.、Medqor、PerkinElmer Inc.、ProDiag B.V.、Sharn Anesthesia, Incなどが含まれています。|
The Global Vein Illuminator Market size was estimated at USD 42.78 million in 2021 and expected to reach USD 55.14 million in 2022, and is projected to grow at a CAGR 29.12% to reach USD 198.33 million by 2027.
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Vein Illuminator to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Near-Infrared Illumination and Trans illumination.
Based on Application, the market was studied across Blood Draw and Intravenous Access.
Based on End User, the market was studied across Academic Institution, Blood Donation Camp, and Hospital.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vein Illuminator market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vein Illuminator Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vein Illuminator Market, including Accuvein, Inc., AIMVEIN LTD., ANANDIC MEDICAL SYSTEMS INC, BLZ Technology Inc.,, CAREstream Group, Kizlon, Koninklijke Philips N.V., MedicalDeals, Medline Industries, Inc., Medqor, PerkinElmer Inc., ProDiag B.V., Sharn Anesthesia, Inc, Soma Technologies International Inc., SURU INTERNATIONAL PVT. LTD., Techno MedicaCo., Ltd., Venoscope, Venoscope, LLC, Vivolight, Vuetek Scientific, LLC, and ZD Medical, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Vein Illuminator Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vein Illuminator Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vein Illuminator Market?
4. What is the competitive strategic window for opportunities in the Global Vein Illuminator Market?
5. What are the technology trends and regulatory frameworks in the Global Vein Illuminator Market?
6. What is the market share of the leading vendors in the Global Vein Illuminator Market?
7. What modes and strategic moves are considered suitable for entering the Global Vein Illuminator Market?
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
188.8.131.52. Growth in phlebotomy/venipuncture procedures
184.108.40.206. Assistant in reducing pain by use of multiple needle sticks
220.127.116.11. Increasing prevalence of venous leg ulcer
18.104.22.168. Existence of alternative methods
22.214.171.124. Strategic alliances for vein illuminators
126.96.36.199. Increase product promotion and sales in untapped markets
188.8.131.52. Limited awareness about the vein illumination technology
5.2. Cumulative Impact of COVID-19
6. Vein Illuminator Market, by Technology
6.2. Near-Infrared Illumination
6.3. Trans illumination
7. Vein Illuminator Market, by Application
7.2. Blood Draw
7.3. Intravenous Access
8. Vein Illuminator Market, by End User
8.2. Academic Institution
8.3. Blood Donation Camp
9. Americas Vein Illuminator Market
9.6. United States
10. Asia-Pacific Vein Illuminator Market
10.10. South Korea
11. Europe, Middle East & Africa Vein Illuminator Market
11.15. Saudi Arabia
11.16. South Africa
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Accuvein, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. AIMVEIN LTD.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ANANDIC MEDICAL SYSTEMS INC
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. BLZ Technology Inc.,
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. CAREstream Group
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Koninklijke Philips N.V.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Medline Industries, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. PerkinElmer Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. ProDiag B.V.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Sharn Anesthesia, Inc
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Soma Technologies International Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. SURU INTERNATIONAL PVT. LTD.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Techno MedicaCo., Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Venoscope, LLC
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Vuetek Scientific, LLC
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. ZD Medical, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
14.1. Discussion Guide
14.2. License & Pricing